Corteva, Inc. current report, 13 May 2020

Business Context and Reporting Period

Corteva, Inc. filed this Form 8-K on May 13, 2020, with the report signed on May 15, 2020. The filing concerns a debt offering by E.I. du Pont de Nemours and Company, doing business as Corteva Agriscience and a direct subsidiary of Corteva.

Financing and Key Financial Metrics

  • 2025 Notes: $500 million aggregate principal amount of 1.700% senior notes due 2025.
  • 2030 Notes: $500 million aggregate principal amount of 2.300% senior notes due 2030.
  • Total issuance: $1.0 billion aggregate principal amount.
  • The notes are senior debt obligations issued under an indenture with U.S. Bank National Association as trustee.
  • The filing does not provide revenue, profit, cash flow, margin, liquidity, existing debt, leverage, or debt-use-of-proceeds figures.

Material Changes and Outlook

This filing reports a new senior-debt financing and does not present operating results, period-over-period comparisons, management guidance, or an updated business outlook. The filing text does not specify the use of proceeds or quantify the effect of the issuance on Corteva’s consolidated liquidity, interest expense, or leverage.

Risks, Contingencies, and Unusual Items

  • The new notes increase the company’s debt obligations and create fixed interest payments of 1.700% through the 2025 maturity and 2.300% through the 2030 maturity, subject to the governing documents.
  • The underwriting agreement, base indenture, supplemental indenture, and note forms contain the operative terms; the filing states that its descriptions are summaries qualified by reference to those documents.
  • The notes were registered under Corteva Agriscience’s Form S-3 registration statement No. 333-231871, as amended.

Important Facts for Investors to Verify

  • Confirm the closing date, issuance price, net proceeds, and application of proceeds in the final offering documents.
  • Review the indenture for covenants, events of default, redemption provisions, guarantees, and payment priorities.
  • Assess the effect of the $1.0 billion issuance on Corteva’s consolidated debt, liquidity, interest expense, and credit metrics.
  • Confirm whether the debt is guaranteed by Corteva, Inc. or other subsidiaries and understand any structural subordination.
  • Review subsequent filings for the completed issuance, debt balances, and any changes to financing plans.